Mechanisms of Soluble Cytokine Receptor Generation
暂无分享,去创建一个
[1] T. S. Wilkinson,et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.
[2] M. Waki,et al. Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism , 1994, European journal of immunology.
[3] P. Wallace,et al. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. , 2004, Immunity.
[4] H. Lemke,et al. CD30 Shedding from Karpas 299 Lymphoma Cells Is Mediated by TNF-α-Converting Enzyme1 , 2000, The Journal of Immunology.
[5] Veronica Huber,et al. Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles , 2002, The Journal of experimental medicine.
[6] S. Ziegler,et al. Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily , 1990, Cell.
[7] S. Rose-John,et al. The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10 1 , 2004, The Journal of Immunology.
[8] R. Black,et al. Stimulation-induced Down-regulation of Tumor Necrosis Factor-α Converting Enzyme* , 2000, The Journal of Biological Chemistry.
[9] S. Dower,et al. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. , 1994, Journal of immunology.
[10] E. Wolf,et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.
[11] R. Derynck,et al. Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide* , 2003, The Journal of Biological Chemistry.
[12] Jian Ni,et al. A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis* , 1999, The Journal of Biological Chemistry.
[13] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[14] J. Dipersio,et al. Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Rose-John,et al. Natural Soluble Interleukin-15Rα Is Generated by Cleavage That Involves the Tumor Necrosis Factor-α-converting Enzyme (TACE/ADAM17)* , 2004, Journal of Biological Chemistry.
[16] C. Blobel,et al. Remarkable roles of proteolysis on and beyond the cell surface. , 2000, Current opinion in cell biology.
[17] R. Kyle,et al. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. , 1992, Cytokine.
[18] E. Ratovitski,et al. Identification of mRNAs encoding two different soluble forms of the human interferon α‐receptor , 1994 .
[19] D. Boraschi,et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.
[20] R. Buller,et al. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein , 1992, Cell.
[21] Wan-Wan Lin,et al. Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action , 2004, Cancer Research.
[22] R. Buller,et al. Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling (*) , 1995, The Journal of Biological Chemistry.
[23] Markus F Neurath,et al. IL-6 trans-signaling: the heat is on. , 2004, Immunity.
[24] G. Weskamp,et al. Evidence for a Critical Role of the Tumor Necrosis Factor α Convertase (TACE) in Ectodomain Shedding of the p75 Neurotrophin Receptor (p75NTR)* , 2004, Journal of Biological Chemistry.
[25] R. Black,et al. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. , 2003, Biochemical and biophysical research communications.
[26] William Clevenger,et al. Cloning and Characterization of an Alternatively Processed Human Type II Interleukin-1 Receptor mRNA* , 1996, The Journal of Biological Chemistry.
[27] G. McFadden,et al. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. , 1991, Virology.
[28] M. Kaler,et al. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Mori,et al. Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.
[30] I. N. Crispe,et al. A naturally occurring soluble isoform of murine Fas generated by alternative splicing , 1995, The Journal of experimental medicine.
[31] Alan I. Alpert,et al. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.
[32] I. Charo,et al. Tumor Necrosis Factor- (cid:1) -converting Enzyme Mediates the Inducible Cleavage of Fractalkine* , 2022 .
[33] J. Peschon,et al. TNF-α-Converting Enzyme Cleaves the Macrophage Colony-Stimulating Factor Receptor in Macrophages Undergoing Activation1 , 2001, The Journal of Immunology.
[34] J. Buxbaum,et al. Tumor Necrosis Factor-α-converting Enzyme Is Required for Cleavage of erbB4/HER4* , 2000, The Journal of Biological Chemistry.
[35] K. Cunnion. Tumor necrosis factor receptors encoded by poxviruses. , 1999, Molecular genetics and metabolism.
[36] D. Nelson,et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.
[37] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[38] F. Fahrenholz,et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.
[39] S. Nagata,et al. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Panus,et al. A third distinct tumor necrosis factor receptor of orthopoxviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Hsieh,et al. Transgenic Expression of Decoy Receptor 3 Protects Islets from Spontaneous and Chemical-induced Autoimmune Destruction in Nonobese Diabetic Mice , 2004, The Journal of experimental medicine.
[42] Dirk E. Smith,et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. , 2003, Immunity.
[43] A. Whitehead,et al. IL-1 Signaling Cascade in Liver Cells and the Involvement of a Soluble Form of the IL-1 Receptor Accessory Protein1 2 , 2000, The Journal of Immunology.
[44] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[45] P. Borchmann,et al. Depletion of Cellular Cholesterol and Lipid Rafts Increases Shedding of CD301 , 2004, The Journal of Immunology.
[46] C. Blobel,et al. Evidence for Regulation of the Tumor Necrosis Factor α-Convertase (TACE) by Protein-tyrosine Phosphatase PTPH1* , 2002, The Journal of Biological Chemistry.
[47] David C. Lee,et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. , 2004, The Journal of biological chemistry.
[48] T. Moseley,et al. Soluble and Transmembrane Isoforms of Novel Interleukin-17 Receptor-like Protein by RNA Splicing and Expression in Prostate Cancer* , 2002, The Journal of Biological Chemistry.
[49] Jun Zhang,et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. , 2002, Immunity.
[50] A. Alcamí,et al. Inhibition of Type 1 Cytokine–mediated Inflammation by a Soluble CD30 Homologue Encoded by Ectromelia (Mousepox) Virus , 2002, The Journal of experimental medicine.
[51] T. Bártfai,et al. Interleukin‐1 receptor accessory protein interacts with the type II interleukin‐1 receptor , 1998, FEBS letters.
[52] J. Lancaster,et al. Activation of Tumor Necrosis Factor-α-converting Enzyme-mediated Ectodomain Shedding by Nitric Oxide* , 2000, The Journal of Biological Chemistry.
[53] A. H. Drummond,et al. Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor* , 1997, The Journal of Biological Chemistry.
[54] J. Lancaster,et al. Reactive oxygen species mediate tumor necrosis factor alpha‐converting, enzyme‐dependent ectodomain shedding induced by phorbol myristate acetate , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] J. Peschon,et al. Tumor Necrosis Factor-α-converting Enzyme Controls Surface Expression of c-Kit and Survival of Embryonic Stem Cell-derived Mast Cells* , 2004, Journal of Biological Chemistry.
[56] Stefan Rose-John,et al. Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)* , 2003, Journal of Biological Chemistry.
[57] J. Bartsch,et al. Therapeutic benefits from targeting of ADAM family members. , 2004, Biochemistry.
[58] M. Labow,et al. Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[59] C. Blobel,et al. Stimulated Shedding of Vascular Cell Adhesion Molecule 1 (VCAM-1) Is Mediated by Tumor Necrosis Factor-α-converting Enzyme (ADAM 17)* , 2003, Journal of Biological Chemistry.
[60] A. Alcamí,et al. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.
[61] M. Arcasoy,et al. Expression of erythropoietin receptor splice variants in human cancer. , 2003, Biochemical and biophysical research communications.
[62] G. Fantuzzi,et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.
[63] R. Black,et al. Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme* , 2000, The Journal of Biological Chemistry.
[64] David C. Lee,et al. Selective Roles for Tumor Necrosis Factor α-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand Family , 2004, Journal of Biological Chemistry.
[65] P. Leung,et al. Identification of Novel Isoforms of Activin Receptor-Like Kinase 7 (ALK7) Generated by Alternative Splicing and Expression of ALK7 and Its Ligand, Nodal, in Human Placenta1 , 2003, Biology of Reproduction.
[66] G. Yancopoulos,et al. The receptor for ciliary neurotrophic factor. , 1991, Science.
[67] R. Junghans,et al. Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding , 1996, The Journal of experimental medicine.
[68] J. Tavernier,et al. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[69] B. de Strooper,et al. Cell–matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation , 2004, The Journal of cell biology.
[70] V. V. van Hinsbergh,et al. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. , 2001, Blood.
[71] I. Juhan-vague,et al. Identification of SAP97 as an intracellular binding partner of TACE , 2003, Journal of Cell Science.
[72] L. Lum,et al. Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival* , 1999, Journal of Biological Chemistry.
[73] R. Black. Tumor necrosis factor-alpha converting enzyme. , 2002, The international journal of biochemistry & cell biology.
[74] M. E. Choi. Cloning and characterization of a naturally occurring soluble form of TGF-beta type I receptor. , 1999, The American journal of physiology.
[75] F. Hofstädter,et al. A soluble form of CD137 (ILA/4‐1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis , 1998, European journal of immunology.
[76] R. Black,et al. Tumor Necrosis Factor-α Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation. , 2000, Endocrinology.
[77] S. Coughlin,et al. Regulated Shedding of PAR1 N-terminal Exodomain from Endothelial Cells* , 2004, Journal of Biological Chemistry.
[78] C. Blobel,et al. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. , 1999, The Biochemical journal.
[79] G. Weskamp,et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.
[80] S. Nagata,et al. Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. , 2003, The Journal of biological chemistry.
[81] D. Botstein,et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer , 1998, Nature.
[82] G Shimamoto,et al. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.
[83] D. Lejeune,et al. Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22 , 2001, The Journal of Immunology.
[84] J. Panus,et al. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[85] M. Neurath,et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. , 2001, European journal of biochemistry.
[86] C. Smith,et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.
[87] S. Rose-John,et al. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. , 2000, European journal of biochemistry.
[88] David C. Lee,et al. An essential role for ectodomain shedding in mammalian development. , 1998, Science.
[89] Guixiu Shi,et al. Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis In Vitro and In Vivo1 , 2003, The Journal of Immunology.
[90] C. Smith,et al. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. , 1994, Virology.
[91] C Upton,et al. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. , 1992, Science.
[92] P. Young,et al. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[93] J. Renauld,et al. Expression cloning of the murine and human interleukin 9 receptor cDNAs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[94] D. Kastner,et al. The TNF Receptor-Associated Periodic Syndrome (TRAPS): Emerging Concepts of an Autoinflammatory Disorder , 2002, Medicine.
[95] T. Yanagida,et al. Engagement of CD44 Promotes Rac Activation and CD44 Cleavage during Tumor Cell Migration* , 2004, Journal of Biological Chemistry.
[96] H Chen,et al. Modulation of T-cell responses to alloantigens by TR6/DcR3. , 2001, The Journal of clinical investigation.
[97] M. Lambert,et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.
[98] Andrea Messori,et al. New drugs for rheumatoid arthritis [6] (multiple letters) , 2004 .
[99] P. Heinrich,et al. The soluble interleukin‐6 receptor is generated by shedding , 1993, European journal of immunology.
[100] A. Alcamí,et al. CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses , 2001, Journal of Virology.
[101] C. Smith,et al. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. , 1996, Virology.
[102] A. Dunne,et al. The Interleukin-1 Receptor/Toll-Like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense , 2000, Science's STKE.
[103] A. Ullrich,et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.
[104] E. Dı́az-Rodrı́guez,et al. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. , 2002, Molecular biology of the cell.
[105] Antonio Alcami,et al. A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection , 1992, Cell.
[106] P. Distefano,et al. Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. , 1993, Science.
[107] J. Arribas,et al. The Shedding of Betaglycan Is Regulated by Pervanadate and Mediated by Membrane Type Matrix Metalloprotease-1* , 2004, Journal of Biological Chemistry.
[108] C. Blobel,et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.
[109] P. Dempsey,et al. A Disintegrin and Metalloproteinase 10-Mediated Cleavage and Shedding Regulates the Cell Surface Expression of CXC Chemokine Ligand 16 , 2004, The Journal of Immunology.
[110] L. Karlsson,et al. Catalytic Activity of ADAM8, ADAM15, and MDC-L (ADAM28) on Synthetic Peptide Substrates and in Ectodomain Cleavage of CD23* , 2003, Journal of Biological Chemistry.
[111] Scott R. Presnell,et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist , 2001, Proceedings of the National Academy of Sciences of the United States of America.